𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer

✍ Scribed by Goto, K; Sekine, I; Nishiwaki, Y; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Niho, S; Kodama, T; Shinkai, T; Tamura, T; Ohe, Y; Kunitoh, H; Yamamoto, N; Nokihara, H; Yoshida, K; Sugiura, T; Matsui, K; Saijo, N

Book ID
109998209
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
127 KB
Volume
91
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of irinotecan, cisplatin
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer
✍ Dean A. Fennell; Jeremy P.C. Steele; Jonathan Shamash; Sarah E. Slater; Michael πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 87 KB πŸ‘ 1 views

## Abstract There is no standard therapy for relapsed small cell lung cancer (rSCLC). We evaluated the efficacy and toxicity of a new triplet consisting of irinotecan (100 mg/m^2^ Days 1 and 15 q28), cisplatin (40 mg/m^2^ Days 1 and 15 q28) and mitomycin (6 mg/m^2^ d1 q28) administered to a maximum

Phase II trial of etoposide and cisplati
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study
✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 466 KB πŸ‘ 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin